Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.
Thank you. Please check your inbox to confirm.
By Dino Hazell, Associated Press
A U.S. company says it's on track to begin a huge study next month to prove if its COVID-19 vaccine candidate really works. Moderna Inc. is developing the experimental shot with the National Institutes of Health.
By Lauran Neergaard, Associated Press
Top officials at the National Institutes of Health will appear before a House appropriations committee Wednesday to address President Donald Trump's budget proposal, which suggests a $3 billion funding cut to the agency.
By Joshua Barajas
Despite the availability of vaccines, the flu still kills tens of thousands of people in the U.S. each year, and hundreds of thousands more worldwide. But public health officials fear that an even graver threat lies ahead: the emergence of…
By William Brangham, Rachel Wellford
The apparent birth this month of the first genetically modified babies is “a lesson in the potential for human hubris to overtake us,” Dr. Francis Collins, the director of the National Institutes of Health.
By Lev Facher, STAT
By Erin Mershon, Ike Swetlitz, STAT
A government shutdown of the FDA, CDC and NIH will likely have widespread and long-lasting consequences for public health.
By Liz Szabo, Kaiser Health News
Less and less of the research presented at a prominent cancer conference is supported by the National Institutes of Health, a development that some of the country’s top scientists see as a worrisome trend.
By Nsikan Akpan
As proposed cuts loom, new research digs into the return on investment for public funding of the National Institutes of Health.
By PBS NewsHour
On Thursday, results from the World Health Organization's two-year trial studying the Ebola virus were published. They indicate that the vaccine is effective -- but it still needs to be approved by regulatory agencies. Hari Sreenivasan speaks with Dr. Anthony…
In Congress, lawmakers are close to passing a major bill that would increase funding for the FDA, the NIH and the effort to fight opioid abuse. The measure would also introduce more flexible standards for drug approvals, reducing the need…
Support Provided By:
Additional Support Provided By: